Hudson Bay Capital Management LP Opti Nose, Inc. Transaction History

Hudson Bay Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$3.2 - $4.98 $960,000 - $1.49 Million	-300,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.69 - $7.09 $369,000 - $709,000	100,000 Added 50.0%	300,000 $1.17 Million
Q2 2020 Aug 12, 2020	SELL	$3.58 - $7.44 $89,500 - $186,000	-25,000 Reduced 11.11%	200,000 $1.49 Million
Q1 2020 May 14, 2020	BUY	$3.49 - $9.2 $87,250 - $229,999	25,000 Added 12.5%	225,000 $1.01 Million
Q4 2019 Feb 12, 2020	BUY	$6.27 - $11.41 $1.25 Million - $2.28 Million	200,000 New	200,000 $1.84 Million

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.